Ajanta Pharma Limited (AJANTPHARM.NS)
Company Info
| ISIN | INE031B01049 |
|---|---|
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
Highlights
| Market Cap | ₹262.59B |
|---|---|
| EPS | ₹58.18 |
| PE Ratio | 35.84 |
| Revenue (TTM) | ₹40.36B |
| Gross Profit (TTM) | ₹26.92B |
| EBITDA (TTM) | ₹10.41B |
| Year Range | ₹1,221.65 - ₹2,326.84 |
| Target Price | ₹2,319.18 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of ₹10,000 in Ajanta Pharma Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Ajanta Pharma Limited had a return of 6.50% year-to-date (YTD) and 72.29% in the last 12 months. Over the past 10 years, Ajanta Pharma Limited had an annualized return of 25.16%, outperforming the S&P 500 benchmark which had an annualized return of 10.52%.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | 6.50% | 6.92% |
| 1 month | 0.00% | -2.83% |
| 6 months | 26.38% | 23.86% |
| 1 year | 72.29% | 23.33% |
| 5 years (annualized) | 28.13% | 11.66% |
| 10 years (annualized) | 25.16% | 10.52% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 4.35% | 2.74% | 1.03% | |||||||||
| 2023 | 4.20% | -2.04% | 12.08% | 5.44% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
Ajanta Pharma Limited(AJANTPHARM.NS)
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Ajanta Pharma Limited (AJANTPHARM.NS) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Ajanta Pharma Limited granted a 1.87% dividend yield in the last twelve months. The annual payout for that period amounted to ₹41.00 per share.
| Period | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | ₹41.00 | ₹15.00 | ₹7.00 | ₹6.33 | ₹6.33 | ₹8.67 | ₹6.00 | ₹4.67 | ₹9.33 | ₹4.00 | ₹2.67 | ₹1.11 |
Dividend yield | 1.87% | 0.72% | 0.58% | 0.42% | 0.58% | 1.33% | 0.76% | 0.47% | 0.79% | 0.45% | 0.43% | 0.44% |
Monthly Dividends
The table displays the monthly dividend distributions for Ajanta Pharma Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | ₹0.00 | ₹26.00 | ₹0.00 | |||||||||
| 2023 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹15.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2022 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹7.00 | ₹0.00 |
| 2021 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.33 | ₹0.00 |
| 2020 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.33 | ₹0.00 |
| 2019 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹8.67 | ₹0.00 |
| 2018 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹6.00 | ₹0.00 |
| 2017 | ₹0.00 | ₹0.00 | ₹4.67 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2016 | ₹0.00 | ₹0.00 | ₹5.33 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 |
| 2015 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹4.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2014 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹2.67 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| 2013 | ₹1.11 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Ajanta Pharma Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Ajanta Pharma Limited was 61.73%, occurring on Oct 27, 2008. Recovery took 298 trading sessions.
The current Ajanta Pharma Limited drawdown is 3.59%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -61.73% | Jul 29, 2005 | 804 | Oct 27, 2008 | 298 | Jan 20, 2010 | 1102 |
| -59% | Jul 10, 2002 | 189 | Mar 31, 2003 | 109 | Aug 29, 2003 | 298 |
| -57.27% | Oct 4, 2016 | 696 | Jul 30, 2019 | 473 | Jun 29, 2021 | 1169 |
| -53.79% | Sep 9, 2003 | 141 | Mar 23, 2004 | 197 | Dec 23, 2004 | 338 |
| -36.62% | Jul 19, 2013 | 28 | Aug 29, 2013 | 39 | Oct 28, 2013 | 67 |
Volatility
Volatility Chart
The current Ajanta Pharma Limited volatility is 7.68%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | 0.00 |
Cost Of Revenue | 0.00 |
Gross Profit | 0.00 |
| Operating Expenses | |
Selling, General & Admin Expenses | 0.00 |
R&D Expenses | 0.00 |
Total Operating Expenses | 0.00 |
| Income | |
Income Before Tax | 0.00 |
Operating Income | 0.00 |
EBIT | 0.00 |
Earnings From Continuing Operations | 0.00 |
Net Income | 0.00 |
Income Tax Expense | 0.00 |
Interest Expense | 0.00 |
Other Non-Operating Income (Expenses) | 0.00 |
Extraordinary Items | 0.00 |
Discontinued Operations | 0.00 |
Effect Of Accounting Charges | 0.00 |
Non Recurring | 0.00 |
Minority Interest | 0.00 |
Other Items | 0.00 |